# AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

> **Open Intelligence Dossier** · First detected: 2026-06-22 14:07 UTC · Category: Business

## Executive Summary
AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics to expand its immunology drug portfolio.

## Intelligence Brief
AbbVie is set to acquire Apogee Therapeutics in a deal valued at $10.9 billion. The acquisition is framed as a strategic effort to enhance the company's research and presence within the immunology sector.


Coverage from Fierce Biotech, The Wall Street Journal, CNBC, and the AbbVie News Center emphasizes the transaction's focus on bolstering the firm's growth in immunology. Reports highlight the inclusion of a specific eczema drug candidate as a primary component of the deal.


Future developments will depend on the finalization of the acquisition process. Coverage does not yet specify the anticipated closing date for the transaction or the specific regulatory hurdles that may remain.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| BioPharma Dive | AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQN25Ld2RhUmVzSzV1M0ctdTl3TkZ2QV9HN3lEc0kycFlrcGU3cTBoQ1o1ekJXcDFaQUFJZFBFMlAwTkZGUjRTUlIxeWlKWDByRVRFbjlqVG9lOU1MbEtSV1VPeUtlNzVQNXF3eGZlaWZHRG5QbW0wam9lMWhIMENjOGlGMXMwcGk5XzFSM0NVdEhPRXhS?oc=5) |
| Yahoo Finance | AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxOb29TSERSM18xZmRJTHV1TW9xN0twQXlZdFZJQWpaYW13b05Ddkp3YnB6ZUkwQUN0UUVNTGw5djZpdkdUZXFfVkZnQ2phdDd0RE5yaGFZMUVxMU9UV19qZWhBc2d6X3cxWjZkaGdRdGpRZmoyeGliYXhUb0hPUHU2bEZtQ1JVbmNwM29PRkZMOU9DZm9BeXZ1MlYwNGxvNnNk?oc=5) |
| Yahoo Finance | AbbVie to acquire Apogee Therapeutics in $10.9B deal | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxNWEJjYkwwZmJQUzRvWV9pSnh3ekNPdUFCbm5Ea0pvRHVHOFNjNW5MeUlYUE9xZ2hWTV82emVfdGYwNUVyelJmYnU4S0VqcFRra1dRV2RyWnNsNHEtV2NfeTkzZ2tjd21Gc2VMNTIwMWN0YXFMblV0WlNuVmdlUXdoSVVZZVQyWTdoSUk3d1V1RTVVVVBTOTd1eXBpcks1cHM?oc=5) |
| Fierce Biotech | AbbVie inks $10.9B Apogee buyout to bag hotly tipped eczema prospect | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxQRzBwWjMyVkN4RkRhS2hoRG5oclBfeWdnY0dfRVFGRnZZeXZjcFF4YXA1eHFjTGdKVU9HNXVDdXVFR3pmOFI2c3pLQkliWWVZMjZzV2ZpWlVRUGFTUzZJSmtsWlZKYlhxMkJ0YU5JVVZ3dlozb3Q4UThHTmJIV1JpdDBWMGJ3a0l1NDE0RnRfS2ZxSHl1bWFkay1uQy1zdFVBTkd3?oc=5) |
| WSJ | AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxPc1M0S3F5YkFqVV9kQkhuVDdxME5oNkhHZU1ON0dhT2NyeFRSejVlV1EzRFFRREljTlNfazdGV2gtOWtHXzNHbFA3T0F2a0JucnlxMFQzNU9DY0UxVVFnSUtvZnJvYTVrWkJFYnFKNkZtR01QcmZoaF83SGdHN05lVjRabFNYTFNrOEhvUEpEdlo4MURxZGszbGZYU2ZNODEyZUxwcg?oc=5) |
| CNBC | AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push | [Source Link](https://news.google.com/rss/articles/CBMiaEFVX3lxTE5KSlczcEh1czRYeXFYdG03cURBeG16b1dyRGd6aHQxOXIwdUJXcDd4cDNmeG5WTl94Yzl6MGJfdDNyZWdsYVF6N25UVDRkMXFSUE1ObTN4SF9PellPY2RvNjg0QlNQVnpY0gFuQVVfeXFMTlF5QTJySmlZR1FTRWRnQ2xRQWpEY1VybEJHQ05naEowY0ZZSmVJMFc5MkNRSTI5MnlLSUNoOElwYkloczZrTjZnbS0xVnpCYUY1bzNOUDZjaXJGS0RmN0pwNEhpR1hGQWt6V1ZkQmc?oc=5) |
| AbbVie News Center | AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxQTGQtbTUzOGFtOFQydVdWOW53bjFOdGpPRkNva2lxY2l2QWIwUFltRU5ZUjNpVG5YQmdtUWNiUlBuZGlaMUNTSEhjWDBNaV9BREJtZVZvVUhrc1JtTldhNG5wYk5PUGUzbHBXS2dsRkpIcG0wa1BGbG5PS2JEMVFSVGg4LVVtVFlEOWt2dDlBTVRwZXRrOVMyeEgxRWJrclZyNmJ5UWg3NA?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-22/abbvie-to-acquire-apogee-therapeutics-deepening-immunology-portfolio*